New drug cocktail aims to tame deadly bile duct cancer
Disease control
Not yet recruiting
This study tests a combination of two immunotherapy drugs (iparomlimab and toripalimab) plus bevacizumab and chemotherapy as a first treatment for advanced biliary tract cancer. It involves 32 adults aged 18-75 who have not had prior treatment for their advanced cancer. The goal …
Phase: PHASE4 • Sponsor: Xianglin Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC